S&P 500   4,567.80 (+0.38%)
DOW   35,950.89 (+1.47%)
QQQ   388.83 (-0.25%)
AAPL   189.95 (+0.31%)
MSFT   378.91 (+0.02%)
META   327.15 (-1.52%)
GOOGL   132.53 (-1.82%)
AMZN   146.09 (-0.16%)
TSLA   240.08 (-1.66%)
NVDA   467.70 (-2.85%)
NIO   7.28 (+1.39%)
BABA   74.86 (+0.25%)
AMD   121.16 (-2.17%)
T   16.57 (+1.66%)
F   10.28 (-2.93%)
MU   76.12 (-0.74%)
CGC   0.56 (+0.00%)
GE   121.74 (+2.42%)
DIS   92.69 (+0.21%)
AMC   6.65 (-7.39%)
PFE   30.44 (+1.20%)
PYPL   57.61 (-0.62%)
XOM   102.80 (+0.45%)
S&P 500   4,567.80 (+0.38%)
DOW   35,950.89 (+1.47%)
QQQ   388.83 (-0.25%)
AAPL   189.95 (+0.31%)
MSFT   378.91 (+0.02%)
META   327.15 (-1.52%)
GOOGL   132.53 (-1.82%)
AMZN   146.09 (-0.16%)
TSLA   240.08 (-1.66%)
NVDA   467.70 (-2.85%)
NIO   7.28 (+1.39%)
BABA   74.86 (+0.25%)
AMD   121.16 (-2.17%)
T   16.57 (+1.66%)
F   10.28 (-2.93%)
MU   76.12 (-0.74%)
CGC   0.56 (+0.00%)
GE   121.74 (+2.42%)
DIS   92.69 (+0.21%)
AMC   6.65 (-7.39%)
PFE   30.44 (+1.20%)
PYPL   57.61 (-0.62%)
XOM   102.80 (+0.45%)
S&P 500   4,567.80 (+0.38%)
DOW   35,950.89 (+1.47%)
QQQ   388.83 (-0.25%)
AAPL   189.95 (+0.31%)
MSFT   378.91 (+0.02%)
META   327.15 (-1.52%)
GOOGL   132.53 (-1.82%)
AMZN   146.09 (-0.16%)
TSLA   240.08 (-1.66%)
NVDA   467.70 (-2.85%)
NIO   7.28 (+1.39%)
BABA   74.86 (+0.25%)
AMD   121.16 (-2.17%)
T   16.57 (+1.66%)
F   10.28 (-2.93%)
MU   76.12 (-0.74%)
CGC   0.56 (+0.00%)
GE   121.74 (+2.42%)
DIS   92.69 (+0.21%)
AMC   6.65 (-7.39%)
PFE   30.44 (+1.20%)
PYPL   57.61 (-0.62%)
XOM   102.80 (+0.45%)
S&P 500   4,567.80 (+0.38%)
DOW   35,950.89 (+1.47%)
QQQ   388.83 (-0.25%)
AAPL   189.95 (+0.31%)
MSFT   378.91 (+0.02%)
META   327.15 (-1.52%)
GOOGL   132.53 (-1.82%)
AMZN   146.09 (-0.16%)
TSLA   240.08 (-1.66%)
NVDA   467.70 (-2.85%)
NIO   7.28 (+1.39%)
BABA   74.86 (+0.25%)
AMD   121.16 (-2.17%)
T   16.57 (+1.66%)
F   10.28 (-2.93%)
MU   76.12 (-0.74%)
CGC   0.56 (+0.00%)
GE   121.74 (+2.42%)
DIS   92.69 (+0.21%)
AMC   6.65 (-7.39%)
PFE   30.44 (+1.20%)
PYPL   57.61 (-0.62%)
XOM   102.80 (+0.45%)

Vera Therapeutics (VERA) Insider Trading & Ownership

$13.55
+0.20 (+1.50%)
(As of 11/30/2023 ET)
Compare
Today's Range
$13.16
▼
$13.88
50-Day Range
$9.29
▼
$15.83
52-Week Range
$5.20
▼
$21.02
Volume
393,619 shs
Average Volume
658,526 shs
Market Capitalization
$602.07 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$23.20
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media

Vera Therapeutics (NASDAQ:VERA) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
22.60%
Number Of
Insiders Buying
(Last 12 Months)
5
Amount Of
Insider Buying
(Last 12 Months)
$22.88 M
Number Of
Insiders Selling
(Last 12 Months)
3
Amount Of
Insider Selling
(Last 12 Months)
$154,718.98
Get VERA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Vera Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

VERA Insider Buying and Selling by Quarter


Vera Therapeutics Insider and Congressional Trades History

Export to Excel
Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/21/2023Celia LinInsiderSell1,490$16.65$24,808.50  
8/21/2023Marshall FordyceCEOSell5,210$16.66$86,798.60  
6/23/2023Sean GrantCFOBuy5,000$16.60$83,000.00  
6/20/2023Commodore Capital LpMajor ShareholderBuy448,217$15.17$6,799,451.89  
3/30/2023Beth C SeidenbergDirectorBuy2,300$7.24$16,652.00  
3/27/2023Beth C SeidenbergDirectorBuy1,633$7.24$11,822.92  
3/24/2023Beth C SeidenbergDirectorBuy1,833$7.24$13,270.92  
3/20/2023Beth C SeidenbergDirectorBuy15,252$7.21$109,966.92  
3/17/2023Beth C SeidenbergDirectorBuy74,045$7.12$527,200.40  
3/15/2023Beth C SeidenbergDirectorBuy32,844$7.12$233,849.28  
3/10/2023Beth C SeidenbergDirectorBuy48,003$7.16$343,701.48  
3/3/2023Beth C SeidenbergDirectorBuy1,000$7.25$7,250.00  
3/1/2023Beth C SeidenbergDirectorBuy100$7.25$725.00  
2/23/2023Beth C SeidenbergDirectorBuy200$7.24$1,448.00  
2/13/2023Beth C SeidenbergDirectorBuy10,072$7.20$72,518.40  
2/8/2023Beth C SeidenbergDirectorBuy45,357$7.22$327,477.54  
2/6/2023Patrick G EnrightDirectorBuy1,714,285$7.00$11,999,995.00  
2/6/2023Sofinnova Venture Partners X,Major ShareholderBuy285,714$7.00$1,999,998.00  
2/3/2023Beth C SeidenbergDirectorBuy46,163$7.24$334,220.12  
12/16/2022Joanne CurleyInsiderSell2,212$19.49$43,111.88  
(Data available from 1/1/2013 forward)












VERA Insider Trading Activity - Frequently Asked Questions

Who is on Vera Therapeutics's Insider Roster?

The list of insiders at Vera Therapeutics includes Beth C Seidenberg, Carlyle Group Inc., Celia Lin, Commodore Capital Lp, Joanne Curley, Llp Abingworth, Marshall Fordyce, Patrick G Enright, Sean Grant, and Sofinnova Venture Partners X,. Learn more on insiders at VERA.

What percentage of Vera Therapeutics stock is owned by insiders?

22.60% of Vera Therapeutics stock is owned by insiders. Learn more on VERA's insider holdings.

Which Vera Therapeutics insiders have been buying company stock?

The following insiders have purchased VERA shares in the last 24 months: Beth C Seidenberg ($2,000,102.98), Commodore Capital Lp ($6,799,451.89), Patrick G Enright ($16,999,990.00), Sean Grant ($151,000.00), and Sofinnova Venture Partners X, ($5,999,988.00).

How much insider buying is happening at Vera Therapeutics?

Insiders have purchased a total of 3,337,017 VERA shares in the last 24 months for a total of $31,950,532.87 bought.

Which Vera Therapeutics insiders have been selling company stock?

The following insiders have sold VERA shares in the last 24 months: Carlyle Group Inc. ($200,981.25), Celia Lin ($24,808.50), Joanne Curley ($1,365,447.38), and Marshall Fordyce ($1,529,810.61).

How much insider selling is happening at Vera Therapeutics?

Insiders have sold a total of 164,536 Vera Therapeutics shares in the last 24 months for a total of $3,121,047.74 sold.


More Insider Trading Tools from MarketBeat

Related Companies:
Insider Tracking Tools:
Insider Trading By Country:
Latest Articles:
This page (NASDAQ:VERA) was last updated on 11/30/2023 by MarketBeat.com Staff

My Account -